CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-26 | Warren Eric Chief Commercial Officer | Option exercise 10b5-1 | +104,124 | $13.24 | $1.4M | 142,524 |
| 2026-06-26 | Warren Eric Chief Commercial Officer | Sale 10b5-1 | −104,124 | $25.90 | $2.7M | 38,400 |
| 2026-06-26 | Warren Eric Chief Commercial Officer | Option exercise · Stock Option 10b5-1 | −104,124 | 252,876 | ||
| 2026-06-17 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +4,167 | $14.25 | $59K | 61,262 |
| 2026-06-17 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +417 | $15.44 | $6K | 61,679 |
| 2026-06-17 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −4,584 | $25.00 | $115K | 57,095 |
| 2026-06-17 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −4,167 | 83,334 | ||
| 2026-06-17 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −417 | 3,750 | ||
| 2026-06-17 | Karydas Daphne Director | Option exercise 10b5-1 | +3,000 | $12.02 | $36K | 9,200 |
| 2026-06-17 | Karydas Daphne Director | Sale 10b5-1 | −3,000 | $25.00 | $75K | 6,200 |
| 2026-06-17 | Karydas Daphne Director | Option exercise · Stock Option 10b5-1 | −3,000 | 38,000 | ||
| 2026-06-15 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +3,542 | $10.20 | $36K | 66,985 |
| 2026-06-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −9,890 | $23.81 | $235K | 57,095 |
| 2026-06-15 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −3,542 | 113,334 | ||
| 2026-06-12 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +6,349 | $1.08 | $7K | 69,792 |
| 2026-06-12 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −6,349 | $23.93 | $152K | 63,443 |
| 2026-06-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −6,349 | 6,349 | ||
| 2026-06-10 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +2,170 | $16.00 | $35K | 65,613 |
| 2026-06-10 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,170 | $25.00 | $54K | 63,443 |
| 2026-06-10 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −2,170 | 17,365 |
Page 3 of 17 · 321 trades